Share This Page

What 400 Alzheimer’s Patients Gained From Leqembi and Kisunla

Leqembi and Kisunla Support Information
In a one-hour seminar, a leading neurologist answers the most important questions families ask about what these new therapies can realistically deliver — from effectiveness and safety to eligibility, infusion logistics, cost, and access. (Video)

Leqembi Library

Leqembi Prescriptions Could Rise Sharply. Why?

Leqembi Prescriptions Could Rise Sharply. Why?

Alzheimer’s treatment eligibility may be far larger than previously thought. A major Nature study using blood tests suggests millions more…
Leqembi: Slowing Alzheimer’s — What You Need to Know

Leqembi: Slowing Alzheimer’s — What You Need to Know

Leqembi is one of the first Alzheimer’s treatments proven to slow decline. A new MRI study helps explain what it…
New At-Home Leqembi: What It Means for Alzheimer's

New At-Home Leqembi: What It Means for Alzheimer's

IMAGINE THIS: Instead of going to an infusion center for treatment, you can switch to a weekly injection at home.…
3-Minute 'Fastball' Alzheimer’s Test Could Speed Access to Leqembi

3-Minute 'Fastball' Alzheimer’s Test Could Speed Access to Leqembi

Access to Leqembi, the new Alzheimer’s drug, has been slowed by lengthy diagnoses. The “Fastball” brainwave test could change that…
Leqembi and Kisunla: Inside the Infusion Experience

Leqembi and Kisunla: Inside the Infusion Experience

They’re not just pills—they’re precision infusions designed to slow Alzheimer’s at its source. See UCLA’s cutting-edge Amyloid Immunotherapy Care Program,…
"Is Leqembi Worth It?" Costs and the Road to Wider Access

"Is Leqembi Worth It?" Costs and the Road to Wider Access

Leqembi, the first Alzheimer's-modifying drug, is a giant step forward—but how many people are getting it, and what does it…
How Many Leqembi Patients Are There?

How Many Leqembi Patients Are There?

Alzheimer's rates are on the rise. How is today's best treatment, Leqembi (generic lecanemab) doing in the fight against it?
Leqembi Best at Fighting Alzheimer's in Men

Leqembi Best at Fighting Alzheimer's in Men

See why Leqembi is even more effective in males than females, at fighting Alzheimer's.
Leqembi Becomes Europe's First Alzheimer's Antibody

Leqembi Becomes Europe's First Alzheimer's Antibody

The European Union authorizes Leqembi as its very first Alzheimer's drug to target an underlying cause of Alzheimer's.
Leqembi & Kisunla: Extending Independent Living

Leqembi & Kisunla: Extending Independent Living

A new analysis of the benefits of these Alzheimer's treatments scores the days and ways patients succeed in living independently.
Leqembi: Europe Checks It's Safety; U.S. Approves Monthly Doses

Leqembi: Europe Checks It's Safety; U.S. Approves Monthly Doses

The EMA has announced its schedule for reviewing the Alzheimer's drug Leqembi (lecanemab) for use in Europe. Meanwhile, the U.S.…
Is Leqembi Shrinking the Alzheimer's or the Brain?

Is Leqembi Shrinking the Alzheimer's or the Brain?

Leqembi and Kisunla are the new Alzheimer's immunotherapies. A loss of brain volume associated with these immunotherapies may be caused…
Catching Up to America: Europe Recommends Leqembi® for Alzheimer's

Catching Up to America: Europe Recommends Leqembi® for Alzheimer's

The European Medicines Agency (EMA) recommended approving Leqembi® (generic lecanemab) for Alzheimer's. Originally skeptics, learn how the "Clarity AD" trial…
Leqembi Autoinjector to Treat Alzheimer's in Seconds, Not Hours

Leqembi Autoinjector to Treat Alzheimer's in Seconds, Not Hours

Leqembi is an FDA-Approved Alzheimer's treatment. Hospital infusions take an hour each. 2025 is looking to see a new 15-second…
3 Questions on Leqembi & Kisunla, the New Alzheimer's Drugs

3 Questions on Leqembi & Kisunla, the New Alzheimer's Drugs

The 2 newest Alzheimer's drugs, Leqembi (lecanemab) and Kisunla (donanemab) show promise, but many questions remain. Here are the three…
Leqembi: Pioneering Alzheimer’s Drug Faces Challenge in Europe

Leqembi: Pioneering Alzheimer’s Drug Faces Challenge in Europe

While the initial headlines might seem discouraging, there’s always more to the story. 🌟
How to Choose Between Kisunla vs. Leqembi, The New Alzheimer's Drugs

How to Choose Between Kisunla vs. Leqembi, The New Alzheimer's Drugs

The newest Alzheimer's drugs, Kisunla and Leqembi, are the first to actually slow down Alzheimer's. How do they compare to…
Leqembi Launched in China to Fight Alzheimer's

Leqembi Launched in China to Fight Alzheimer's

China is the third country to launch LEQEMBI for sale, to fight Alzheimer's, following the United States and Japan.
Making it Easier to Take Leqembi for Alzheimer's

Making it Easier to Take Leqembi for Alzheimer's

A drug for Alzheimer’s, called Leqembi, might soon be given less often. Right now, patients get it through a drip…
What Treats Alzheimer's Better? Leqembi or a Plant Based Diet?

What Treats Alzheimer's Better? Leqembi or a Plant Based Diet?

Dr. Dean Ornish publishes the first trial investigating plant-based diets fighting or reversing early-stage Alzheimer's. The results are eye-opening.
LEQEMBI® for Alzheimer’s Now in USA, China, Japan, South Korea

LEQEMBI® for Alzheimer’s Now in USA, China, Japan, South Korea

South Korea joined other countries in approving LEQEMBI® (generic lecanemab) for mild cognitive impairment, mild and early Alzheimer's. Learn how…
Leqembi Injection, an Easier Alzheimer's Treatment, Awaits FDA Approval

Leqembi Injection, an Easier Alzheimer's Treatment, Awaits FDA Approval

LEQEMBI® is the newest Alzheimer's drug. It is administered in hospitals via IV. Biogen applied to the FDA for approval…
Carolyn Davis Talks About Her Leqembi Infusions

Carolyn Davis Talks About Her Leqembi Infusions

The newest and most promising drug to fight Alzheimer's is Leqembi. Carolyn Davis is giving it a try. Learn about…
Leqembi for Alzheimer's: Patient and Doctor Hopeful After First 6 Months

Leqembi for Alzheimer's: Patient and Doctor Hopeful After First 6 Months

The first doses of the newly approved Alzheimer's drug "Leqembi" were administered in Louisville. More than 100 people have signed…
Aduhelm for Alzheimer's Discontinued. Is Leqembi Any Better?

Aduhelm for Alzheimer's Discontinued. Is Leqembi Any Better?

Biogen reprioritize resources allocated to ADUHELM® to advance LEQEMBI®.
Leqembi: An Alzheimer's Drug Worth Rooting For?

Leqembi: An Alzheimer's Drug Worth Rooting For?

At long last, we finally have a disease-modifying drug for Alzheimer’s. The FDA recently approved a new drug that promises…
Alzheimer's Drug Leqembi Gets Full FDA and MEDICARE Approval

Alzheimer's Drug Leqembi Gets Full FDA and MEDICARE Approval

First drug to modestly slow Alzheimer's cognitive decline, based on 1,800 patients.
FDA Unanimously Votes Leqembi Benefits Alzheimer's

FDA Unanimously Votes Leqembi Benefits Alzheimer's

The FDA Advisory Committee's endorsement of Leqembi paves way for traditional approval, ushers in a new era for Alzheimer's
Lecanemab Can Delay Alzheimer’s 8 Years: New Data, New Hope

Lecanemab Can Delay Alzheimer’s 8 Years: New Data, New Hope

New long-term data suggests lecanemab could delay the shift from mild memory loss to moderate Alzheimer’s by up to eight…
Arginine on the Frontline: New Hope for Alzheimer’s

Arginine on the Frontline: New Hope for Alzheimer’s

A new study suggests a simple nutrient — arginine — may reduce amyloid-β buildup in Alzheimer’s. The findings, from animal…

Related:

Email me when people comment
Notify of
guest

0 Comments
Inline Feedbacks
View all comments
By:
Picture of Peter Berger

Peter Berger

With experience in dementia caregiving, public education, and Alzheimer’s-focused writing—and a professional research background shaped in what many consider one of the world’s top laboratories—I work to make complex findings clear, practical, and genuinely helpful for families and professionals providing care.

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

Share this page To

Dementia Books & Videos on Amazon:

More From Alzheimer's Weekly

Diagnosis

Is Forgetfulness Normal or Not?

It’s normal to forget things once in a while as the years pass, but how can you tell whether those memory lapses are a sign of something more serious — like Alzheimer’s?

Read More »
Share to Facebook
Twitter
LinkedIn

Visit Alzheimer's Weekly On

Welcome

Alzheimer’s & Dementia Weekly was inspired by my mother’s journey with autoimmune dementia and my dad’s with Parkinson’s dementia.

Walking beside them opened my eyes to the confusion, the courage, and the deep humanity found in families and professionals caring for someone they love.

Since its debut in 2007, this site has had one clear mission:
to separate the wheat from the chaff — to highlight only the most essential articles, studies, tools, and videos from the overwhelming river of dementia-related information.
(At last count, Google receives a new post on Alzheimer’s or dementia every seven minutes.) For anyone seeking clarity or support, that constant flow can be exhausting and discouraging.

Alzheimer’s Weekly filters, translates, and explains what matters most, helping hundreds of thousands of families, clinicians, and care teams around the world make sense of the latest research and best practices.

This site is dedicated to everyone who works—often quietly and tirelessly—to preserve dignity in the community of people living with dementia.


About the Editor

With experience in dementia caregiving, public education, and Alzheimer’s-focused writing—and a professional research background shaped in what many consider one of the world’s top laboratories—I work to make complex findings clear, practical, and genuinely helpful for both families and professionals providing care.

My goal is simple:
Translate the best science into guidance that lightens the load, strengthens understanding, and helps every person with dementia live with dignity.

Peter Berger
Editor, Alzheimer’s Weekly

Free:
Alzheimer's & Dementia
Weekly Newsletter

INCLUDES BONUS BOOKLET:
15 Simple Things You Can Do to Care For a Loved One with Dementia or Memory Loss
News, Treatments, Care Tips, Diet, Research, Diagnosis, Therapies & Prevention
News to Get at the Truth

Subscribe To Our Weekly Newsletter

0
Would love your thoughts, please comment.x
()
x